BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 30805957)

  • 1. Seeding variability of different alpha synuclein strains in synucleinopathies.
    Candelise N; Schmitz M; Llorens F; Villar-Piqué A; Cramm M; Thom T; da Silva Correia SM; da Cunha JEG; Möbius W; Outeiro TF; Álvarez VG; Banchelli M; D'Andrea C; de Angelis M; Zafar S; Rabano A; Matteini P; Zerr I
    Ann Neurol; 2019 May; 85(5):691-703. PubMed ID: 30805957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RT-QuIC Using C-Terminally Truncated α-Synuclein Forms Detects Differences in Seeding Propensity of Different Brain Regions from Synucleinopathies.
    Poggiolini I; Erskine D; Vaikath NN; Ponraj J; Mansour S; Morris CM; El-Agnaf OMA
    Biomolecules; 2021 May; 11(6):. PubMed ID: 34072869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrasensitive Detection of Aggregated α-Synuclein in Glial Cells, Human Cerebrospinal Fluid, and Brain Tissue Using the RT-QuIC Assay: New High-Throughput Neuroimmune Biomarker Assay for Parkinsonian Disorders.
    Manne S; Kondru N; Hepker M; Jin H; Anantharam V; Lewis M; Huang X; Kanthasamy A; Kanthasamy AG
    J Neuroimmune Pharmacol; 2019 Sep; 14(3):423-435. PubMed ID: 30706414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the micro-environment on α-synuclein conversion and implication in seeded conversion assays.
    Candelise N; Schmitz M; Thüne K; Cramm M; Rabano A; Zafar S; Stoops E; Vanderstichele H; Villar-Pique A; Llorens F; Zerr I
    Transl Neurodegener; 2020; 9():5. PubMed ID: 31988747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Streamlined alpha-synuclein RT-QuIC assay for various biospecimens in Parkinson's disease and dementia with Lewy bodies.
    Bargar C; Wang W; Gunzler SA; LeFevre A; Wang Z; Lerner AJ; Singh N; Tatsuoka C; Appleby B; Zhu X; Xu R; Haroutunian V; Zou WQ; Ma J; Chen SG
    Acta Neuropathol Commun; 2021 Apr; 9(1):62. PubMed ID: 33827706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of skin α-synuclein using RT-QuIC as a diagnostic biomarker for Parkinson's disease in the Chinese population.
    Li J; Duan S; Yang J; Zheng H; Yuan Y; Tang M; Wang Y; Liu Y; Xia Z; Luo H; Xu Y
    Eur J Med Res; 2024 Feb; 29(1):114. PubMed ID: 38336827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrasensitive RT-QuIC assay with high sensitivity and specificity for Lewy body-associated synucleinopathies.
    Rossi M; Candelise N; Baiardi S; Capellari S; Giannini G; Orrù CD; Antelmi E; Mammana A; Hughson AG; Calandra-Buonaura G; Ladogana A; Plazzi G; Cortelli P; Caughey B; Parchi P
    Acta Neuropathol; 2020 Jul; 140(1):49-62. PubMed ID: 32342188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical Detection of Alpha-Synuclein Seeding Activity in the Colon of a Transgenic Mouse Model of Synucleinopathy by RT-QuIC.
    Han JY; Shin C; Choi YP
    Viruses; 2021 Apr; 13(5):. PubMed ID: 33926043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha-synuclein seeds in olfactory mucosa of patients with isolated REM sleep behaviour disorder.
    Stefani A; Iranzo A; Holzknecht E; Perra D; Bongianni M; Gaig C; Heim B; Serradell M; Sacchetto L; Garrido A; Capaldi S; Sánchez-Gómez A; Cecchini MP; Mariotto S; Ferrari S; Fiorini M; Schmutzhard J; Cocchiara P; Vilaseca I; Brozzetti L; Monaco S; Jose Marti M; Seppi K; Tolosa E; Santamaria J; Högl B; Poewe W; Zanusso G;
    Brain; 2021 May; 144(4):1118-1126. PubMed ID: 33855335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. α-Synuclein Seeding Assay Using RT-QuIC.
    Okuzumi A; Hatano T; Fukuhara T; Ueno S; Nukina N; Imai Y; Hattori N
    Methods Mol Biol; 2021; 2322():3-16. PubMed ID: 34043187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. α-Synuclein conformers reveal link to clinical heterogeneity of α-synucleinopathies.
    Schmitz M; Candelise N; Canaslan S; Altmeppen HC; Matschke J; Glatzel M; Younas N; Zafar S; Hermann P; Zerr I
    Transl Neurodegener; 2023 Mar; 12(1):12. PubMed ID: 36915212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropathology and molecular diagnosis of Synucleinopathies.
    Koga S; Sekiya H; Kondru N; Ross OA; Dickson DW
    Mol Neurodegener; 2021 Dec; 16(1):83. PubMed ID: 34922583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prion-Like Seeding of Misfolded α-Synuclein in the Brains of Dementia with Lewy Body Patients in RT-QUIC.
    Sano K; Atarashi R; Satoh K; Ishibashi D; Nakagaki T; Iwasaki Y; Yoshida M; Murayama S; Mishima K; Nishida N
    Mol Neurobiol; 2018 May; 55(5):3916-3930. PubMed ID: 28550528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain and Cerebrospinal Fluid α-Synuclein Real-Time Quaking-Induced Conversion Identifies Lewy Body Pathology in LRRK2-PD.
    Garrido A; Fairfoul G; Tolosa E; Marti MJ; Ezquerra M; Green AJE
    Mov Disord; 2023 Feb; 38(2):333-338. PubMed ID: 36471633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Path mediation analysis reveals GBA impacts Lewy body disease status by increasing α-synuclein levels.
    Gündner AL; Duran-Pacheco G; Zimmermann S; Ruf I; Moors T; Baumann K; Jagasia R; van de Berg WDJ; Kremer T
    Neurobiol Dis; 2019 Jan; 121():205-213. PubMed ID: 30236861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathological α-synuclein detected by real-time quaking-induced conversion in synucleinopathies.
    Huang J; Yuan X; Chen L; Hu B; Wang H; Wang Y; Huang W
    Exp Gerontol; 2024 Mar; 187():112366. PubMed ID: 38280659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of Method for the Determination of Aggregated α-Synuclein in DLB Patient Using RT-QuIC Assay.
    Park SJ; Lee YJ; Park JH; Jin HT; Choi MJ; Jung CG; Akatsu H; Choi EK; Kim YS
    Protein Pept Lett; 2021; 28(1):115-120. PubMed ID: 32310037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of αSynuclein RT-QuIC in relation to neuropathological staging of Lewy body disease.
    Hall S; Orrù CD; Serrano GE; Galasko D; Hughson AG; Groveman BR; Adler CH; Beach TG; Caughey B; Hansson O
    Acta Neuropathol Commun; 2022 Jun; 10(1):90. PubMed ID: 35733234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between CSF alpha-synuclein seeding activity and genetic status in Parkinson's disease and dementia with Lewy bodies.
    Brockmann K; Quadalti C; Lerche S; Rossi M; Wurster I; Baiardi S; Roeben B; Mammana A; Zimmermann M; Hauser AK; Deuschle C; Schulte C; Waniek K; Lachmann I; Sjödin S; Brinkmalm A; Blennow K; Zetterberg H; Gasser T; Parchi P
    Acta Neuropathol Commun; 2021 Oct; 9(1):175. PubMed ID: 34717775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic value of cerebrospinal fluid alpha-synuclein seed quantification in synucleinopathies.
    Poggiolini I; Gupta V; Lawton M; Lee S; El-Turabi A; Querejeta-Coma A; Trenkwalder C; Sixel-Döring F; Foubert-Samier A; Pavy-Le Traon A; Plazzi G; Biscarini F; Montplaisir J; Gagnon JF; Postuma RB; Antelmi E; Meissner WG; Mollenhauer B; Ben-Shlomo Y; Hu MT; Parkkinen L
    Brain; 2022 Apr; 145(2):584-595. PubMed ID: 34894214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.